Exelixis, Inc.

As of June 30, 2026, Exelixis, Inc. carries a market capitalization of 10.61B, placing it among publicly traded companies globally. Its enterprise value stands at 10.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Exelixis, Inc.'s next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Exelixis, Inc. has 248.89M shares outstanding.

As of June 30, 2026, Exelixis, Inc. trades at a trailing price-to-earnings ratio of 16.00. The price-to-sales ratio is 5.65, and the price-to-book ratio stands at 7.12.

As of June 30, 2026, Exelixis, Inc. trades at an EV/EBITDA multiple of 12.46 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.82 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Exelixis, Inc. trades at an EV/FCF ratio of 10.75, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 10.06B versus a market cap of 10.61B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Exelixis, Inc. maintains a current ratio of 3.46, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Exelixis, Inc. posted a return on equity (ROE) of 44.39, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 38.24 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 33.28, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 40.76, useful for judging operating efficiency across full business cycles. The company generates approximately 1.80M in revenue per employee across its workforce of 1,094.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.28 indicates how many times Exelixis, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Exelixis, Inc. recorded 141.24M in income tax expense. That works out to an effective tax rate of 16.89, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 836.48M, leaving 695.24M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 21, 2026, Exelixis, Inc.'s stock has gained approximately 78.49% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Exelixis, Inc. generated 1.97B in revenue and converted that into 695.24M in net income, yielding earnings per share of 2.57. EBITDA reached 807.68M, while operating income came in at 801.38M.

As of June 30, 2026, Exelixis, Inc. holds 678.08M in cash and equivalents against 134.04M in total debt, resulting in a net debt position of -227.36M. Total book value stands at 1.49B, with working capital of 718.08M providing operational flexibility.

Exelixis, Inc. produced 956.00M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -20.39M in capital expenditures, free cash flow totaled 935.62M - equivalent to 3.58 per share.

Over the twelve months ended June 30, 2026, Exelixis, Inc. posted a gross margin of 96.48, reflecting its pricing power and cost economics. The operating margin of 40.72 and net profit margin of 35.33 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 8.12, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 8.83, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Exelixis, Inc. shareholders.

As of June 30, 2026, Exelixis, Inc. has an Altman Z-Score of 14.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.